MedTrace Logo

DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC

NCT01509430 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2016-11-29

No results posted yet for this study

Summary

Head and neck cancer patients often experience a critical weight loss of around 10% following radiation therapy. Of this up to 70% is muscle mass and is an independent predictor of mortality, lowers muscle strength and functional performance. The purpose of this study is in a randomized controlled trial to investigate the effects of progressive resistance training (PRET) on changes in muscle mass, muscle strength and functional performance in head and neck cancer survivors. The investigators hypothesize that PRET has a positive effect on all primary endpoints and increases muscle mass, muscle strength and functional performance.

Conditions

Interventions

OTHER

Progressive Resistance Exercise Training

12 weeks of Progressive Resistance Exercise Training followed by 12 weeks of self chosen training

OTHER

Progressive Resistance Exercise Training

12 weeks of self chosen training followed by 12 weeks of progressive resistance exercise training

Sponsors & Collaborators

  • Danish Head and Neck Cancer Group

    lead NETWORK

Principal Investigators

  • Jens Overgaard, Prof., MD · Danish Head and Neck Cancer Group

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509430 on ClinicalTrials.gov